Dr. John Cush RheumNow
2 years 8 months ago
The SMART Study: Split Dose Oral Methotrexate
Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego.
https://t.co/STybvwt9N5 https://t.co/BTwstJiFHr https://t.co/vfb2A5zZAp
Dr. John Cush RheumNow
2 years 8 months ago
Biologics as First-line Therapy for PMR and GCA?
Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset?
https://t.co/eezZkBr8x7 https://t.co/D0dTSkjsNS https://t.co/nBlFyKNkHM
Dr. John Cush RheumNow
2 years 8 months ago
Can Rheumatologists Accurately Diagnose axSpA in Patients w/Chronic Back Pain?
Chronic low back pain is a common complaint that patients bring to the doctor’s attention.
https://t.co/dnlRtjsUHl https://t.co/wQq1J4Iudf https://t.co/24dQSWlwdr
Dr. John Cush RheumNow
2 years 8 months ago
"Protein kinases: drug targets for immunological disorders". Great full-read review from J Shea et al. Reviews Hx, biology, clinical use and safetey of Kinase targeted therapy. https://t.co/T4qMZG2DLI https://t.co/xANcLeiGr6 https://t.co/wAknXuvjl4
Dr. John Cush RheumNow
2 years 8 months ago
Check out this engaging video exploring the pathophysiology and management of gout flares. https://t.co/wgxUIkdJ7v https://t.co/kWRGXfPeYz
Dr. John Cush RheumNow
2 years 8 months ago
Early bird pricing has been extended! Register today!
https://t.co/DSyFGlEJZx https://t.co/T0QoRCn3tK
Dr. John Cush RheumNow
2 years 8 months ago
PR3+ in Lupus Nephritis
https://t.co/rLdlAQYCfT https://t.co/CzLotVPwlh
Dr. John Cush RheumNow
2 years 8 months ago
Check out this engaging video exploring the pathophysiology and management of gout flares. https://t.co/LNmXZyDec1 https://t.co/nKojprg9mU
Dr. John Cush RheumNow
2 years 8 months ago
Next generation JAK-inhibition strategies
As there are many JAK-inhibitors evaluated in clinical trials currently, how do you stand out?
https://t.co/Pm6cCK5ltN https://t.co/h9z3nku1gZ
Dr. John Cush RheumNow
2 years 8 months ago
UKs MHRA issued a safety alert #MTX maybe associated w/ photosensitivity. Based on Coroners death (by secondary infx) report assoc w/ photosensitivity Rxn in a MTX Rx pt. Warning is because this is not a well-known side effect https://t.co/Vbl9BYMMNC https://t.co/9SyYQMTXTl https://t.co/JNqvNieqrt
Dr. John Cush RheumNow
2 years 8 months ago
Chemokine CXCL10 a potential biomarker for ILD in systemic sclerosis (SSc)? Study of 165 SSc pts (41 w/ SSc-ILD) found higher serum CXCL10 in SSc-ILD (126 vs. 78.5 pg/ml). Hi levels incr risk of ILD 2.74-fold. Most CXCL10 from inflammed lung tissues https://t.co/Z8pIAZYaC0 https://t.co/ErRsD9Msn1
Whether it’s RA, SLE or Sjogren’s, the increased prevalence of females affected by auto-immune diseases is well established, yet not fully understood. Often, I have heard that sexual hormones are responsible for every aspect of it. Two abstracts presented this year question this paradigm.
A lot of interesting studies will be presented at the poster sessions on Sunday, November 12 and some of them address practical real-world issues such as treatment intensification and the impact of pregnancy on axSpA imaging.
Dr. Jack Cush reviews this past week's news and journal reports from RheumNow.com. Good news is that nearly 99% of adult rheumatology positions matched! But the challenge is that 45% of pediatric fellowship programs and 39% of pediatric rheum slots were unfilled in the 2024 NRMP match.
